# Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid

> **NCT00888446** · PHASE2 · COMPLETED · sponsor: **International AIDS Vaccine Initiative** · enrollment: 91 (actual)

## Conditions studied

- Human Immunodeficiency Virus Infections
- HIV Infections

## Interventions

- **BIOLOGICAL:** tgAAC09
- **BIOLOGICAL:** tgAAC09
- **BIOLOGICAL:** tgAAC09
- **OTHER:** Formulation buffer

## Key facts

- **NCT ID:** NCT00888446
- **Lead sponsor:** International AIDS Vaccine Initiative
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2012-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888446, "Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00888446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*